PANG — Pangaea Oncology SA Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Annual balance sheet for Pangaea Oncology SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	R2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	Interim Report	ARS	ARS
Standards:	SAS	SAS	SAS	SAS	SAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	1.42	1.17	1.04	2.93	8.51
Net Total Accounts Receivable
Net Total Receivables	3.74	3.67	3.97	4.08	4.38
Total Inventory
Total Current Assets	5.46	5.13	5.49	7.52	13.3
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.796	0.639	0.553	0.429	0.353
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	20.4	16.9	17	20.8	28.4
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	4.96	5.01	4.68	3.18	2.72
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	11.7	8.56	8.72	6.76	5.49
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	8.62	8.31	8.24	14.1	22.9
Total Liabilities & Shareholders' Equity	20.4	16.9	17	20.8	28.4
Total Common Shares Outstanding